Clinical trial
Enhancing the Lucentis (Ranibizumab) Management of Choroidal Neovascular Membranes With Hyperspectral Imaging
NCT03105609 is registered in ClinicalTrials.gov with Center for Eye Research Australia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Enhancing the Lucentis (Ranibizumab) Management of Choroidal Neovascular Membranes With Hyperspectral Imaging
- Lead sponsor
- Center for Eye Research Australia
- Phase
- Observational
- Overall status
- Terminated
- Start date
- November 14, 2017
- Completion date
- December 1, 2018
- Enrollment
- 4 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.